Citi maintains a 'Buy' on Covidien Ltd (NYSE: COV), but lowers price target from $52 to $48.

Citi analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE